Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-05
2006-12-05
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S364000, C514S384000, C548S321100, C548S132000, C548S263200
Reexamination Certificate
active
07144908
ABSTRACT:
The present invention relates to novel compounds of formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
REFERENCES:
patent: 4990505 (1991-02-01), Skidmore et al.
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 0 162 576 (1985-11-01), None
patent: 0 220 054 (1987-04-01), None
patent: 0 220 878 (1987-05-01), None
patent: 0 223 410 (1987-05-01), None
patent: 0 286 242 (1988-10-01), None
patent: 0 303 465 (1989-02-01), None
patent: 0 317 206 (1989-05-01), None
patent: 0 416 951 (1991-03-01), None
patent: 2140800 (1984-12-01), None
patent: 2 159 151 (1985-11-01), None
patent: 2 162 842 (1986-02-01), None
patent: 95/01170 (1995-01-01), None
Coe Diane Mary
Monteith Michael John
Procopiou Panayiotis Alexandrou
Barker Michael P.
Smith Robert J.
LandOfFree
Agonists of beta-adrenoceptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agonists of beta-adrenoceptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agonists of beta-adrenoceptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3710891